Skip to main content

Nasdaq Stocks

First Week of CVE December 18th Options Trading

6 years 5 months ago
Investors in Cenovus Energy Inc. (Symbol: CVE) saw new options begin trading this week, for the December 18th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 241 days until expiration the newly trading c
BNK Invest

KNX Makes Notable Cross Below Critical Moving Average

6 years 5 months ago
In trading on Tuesday, shares of Knight-Swift Transportation Holdings Inc (Symbol: KNX) crossed below their 200 day moving average of $35.53, changing hands as low as $35.18 per share. Knight-Swift Transportation Holdings Inc shares are currently trading off about 1.6% on the
BNK Invest

First Week of June 19th Options Trading For DHT Holdings

6 years 5 months ago
Investors in DHT Holdings Inc (Symbol: DHT) saw new options begin trading this week, for the June 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the DHT options chain for the new June 19th contracts and identified one put and one cal
BNK Invest

Insiders Bullish on Certain Holdings of DEW

6 years 5 months ago
A look at the weighted underlying holdings of the WisdomTree Global High Dividend Fund (DEW) shows an impressive 13.3% of holdings on a weighted basis have experienced insider buying within the past six months. Emerson Electric Co. (Symbol: EMR), which makes up 0.27% of the
BNK Invest

Strong Insider Buying Found in the Underlying Holdings of DIVB

6 years 5 months ago
A look at the weighted underlying holdings of the iShares U.S. Dividend and Buyback ETF (DIVB) shows an impressive 20.3% of holdings on a weighted basis have experienced insider buying within the past six months. Humana Inc. (Symbol: HUM), which makes up 0.14% of the iShares
BNK Invest

Roche's Ocrevus Line Extension Application Moves Forward

6 years 5 months ago
Roche RHHBY announced that the FDA has accepted a supplemental Biologics License Application (sBLA), seeking approval for a shorter infusion time for its multiple sclerosis (“MS”) drug, Ocrevus. The sBLA, if approved, will reduce infusion time from the current three-and-a-ha
Zacks

Analysts Predict 15% Upside For The Holdings of IYY

6 years 5 months ago
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itse
BNK Invest

How The Parts Add Up: DYNF Headed For $28

6 years 5 months ago
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itse
BNK Invest

Add Up The Parts: IWF Could Be Worth $186

6 years 5 months ago
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itse
BNK Invest

How The Pieces Add Up: IVW Headed For $204

6 years 5 months ago
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itse
BNK Invest

WPM Crosses Above Average Analyst Target

6 years 5 months ago
In recent trading, shares of Wheaton Precious Metals Corp (Symbol: WPM) have crossed above the average analyst 12-month target price of $34.59, changing hands for $34.98/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: dow
BNK Invest

TYL Crosses Above Average Analyst Target

6 years 5 months ago
In recent trading, shares of Tyler Technologies, Inc. (Symbol: TYL) have crossed above the average analyst 12-month target price of $328.00, changing hands for $328.05/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downg
BNK Invest
Checked
20 minutes 36 seconds ago
This feed is responsible for generating the rss feed related to the topic Stocks
Subscribe to Nasdaq Stocks feed